NCT06298656View on ClinicalTrials.gov

Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF Patients

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 10, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Acute-On-Chronic Liver Failure
Interventions
OTHER

No intervention

It is an observational study.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences (ILBS), New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT06298656 - Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF Patients | Biotech Hunter | Biotech Hunter